Get started
Author

Wendy Joyce Sherman

Observed names: W Sherman, WJ Sherman, Wendi Sherman, Wendy J Sherman, Wendy J. Sherman, Wendy J. Sherman Sojka, Wendy Sherman
Observed institutions: Northwestern University, Mayo Clinic, Spectrum Health, University of Massachusetts Chan Medical School, Brown University, Rhode Island Hospital, Corewell Health Blodgett Hospital, Mayo Clinic in Florida, Lifespan, Michigan State University
ORCID: 0000-0002-1321-0600
Observed ORCID: 0000-0002-1321-0600
OpenAlex ID: A5080527031
Influence of supramarginal resection on survival outcomes after gross-total resection of IDH–wild-type glioblastoma
2021 · Tito Vivas-Buitrago, Ricardo A. Domingo, et al. · Journal of neurosurgery · 98
PDF
Delivery mode is a major environmental determinant of stress urinary incontinence: Results of the Evanston-Northwestern Twin Sisters Study
2005 · Roger P. Goldberg, Yoram Abramov, et al. · American Journal of Obstetrics and Gynecology · 91
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study
2022 · Andres Ramos-Fresnedo, Michael W. Pullen, et al. · Journal of Neuro-Oncology · 68
Chemotherapy: what is its role in meningioma?
2012 · WJ Sherman, JJ Raizer · Expert Review of Neurotherapeutics · 26
PDF
Do alterations in vaginal dimensions after reconstructive pelvic surgeries affect the risk for dyspareunia?
2005 · Yoram Abramov, Sanjay Gandhi, et al. · American Journal of Obstetrics and Gynecology · 26
Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification
2023 · Anteneh M. Feyissa, Sofia S. Sanchez-Boluarte, et al. · Seizure · 16
PDF
Early Postoperative Seizures Following Awake Craniotomy and Functional Brain Mapping for Lesionectomy
2023 · Brin E. Freund, Anteneh M. Feyissa, et al. · World Neurosurgery · 15
Stroke code simulation benefits advanced practice providers similar to neurology residents
2018 · Muhib Khan, Grayson L. Baird, et al. · Neurology Clinical Practice · 13
Neuro-oncologic Emergencies
2022 · Paola Suarez-Meade, Lina Marenco-Hillembrand, et al. · Current Oncology Reports · 11
Outcomes and Surgical Considerations for Neurosurgical Patients Hospitalized with COVID-19–A Multicenter Case Series
2021 · Lina Marenco-Hillembrand, Young Erben, et al. · World Neurosurgery · 10
Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer
2008 · Roger P. Goldberg, Wendy Sherman, et al. · International Urogynecology Journal · 9
Nivolumab with radiation therapy in a glioblastoma patient with Lynch syndrome
2021 · Wendy Joyce Sherman, Todd W Vitaz · BMJ Case Reports · 8
Medical management of meningiomas
2013 · Wendy J Sherman, Jeff J Raizer · CNS Oncology · 7
Outcome of discontinuing bevacizumab prior to malignant glioma progression
2012 · Wendy J. Sherman, Jeffrey J. Raizer, et al. · Journal of Neuro-Oncology · 7
Primary and Specialist Palliative Care in Neurosurgery: A Narrative Review and Bibliometric Analysis of Glioblastoma and Stroke
2023 · Daniel Jeremiah Harrison, Emily Wu, et al. · World Neurosurgery · 6
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies
2025 · Brin E. Freund, Anteneh M. Feyissa, et al. · Neurology · 4
PDF
Ctni-74. Primary Results of the Randomized Clinical Trial of Berubicin Vs Lomustine in Patients With Glioblastoma After Failure of Primary Therapy: Data Analysis and Future Possibilities
2025 · Mustafa Kashraw, Erin Dunbar, et al. · Neuro-Oncology · 2
PDF
Rapid early progression of glioblastoma: evaluation of a novel prognostic radiologic biomarker
2025 · Jacob Guzzino, David J. Crompton, et al. · Journal of Neuro-Oncology · 2
Acute Symptomatic Seizures During CAR T-Cell Therapy for Hematologic Malignancies: Tri-Site Mayo Clinic Experience (S20.003)
2025 · Brin Freund, Andy Shar, et al. · Neurology · 1
Schwannoma response to interferon alpha
2017 · Jennifer Novak, Wendy J. Sherman, et al. · Interdisciplinary Neurosurgery · 1
PDF
Meningiomas
2012 · Jeffrey Raizer, Wendy J. Sherman Sojka · Neuro-Oncology · 1
IMG-26. Clinical utility of RANO 2.0 for response assessment to immunotherapy in recurrent gliomas
2025 · Shameel Shafqat, Muhammad Asad Maqbool, et al. · Neuro-Oncology
NCOG-44. Experience with vorasidenib in patients with grade 3 or 4 IDH-mutant gliomas
2025 · Amanda Knott, Sydney Schultz, et al. · Neuro-Oncology
Ctni-08. Wsd0922-fu Therapy in Patients With Egfr Mutant Glioblastoma – Updates From the Dose Expansion Cohorts of a First-in-human Phase 1 Clinical Trial (mc1914)
2025 · Sani Kizilbash, Kurt Jaeckle, et al. · Neuro-Oncology
PDF
The impact of IDH mutation and 1p/19q codeletion on immune-checkpoint inhibitor efficacy in recurrent gliomas.
2025 · Shameel Shafqat, Muhammad Asad Maqbool, et al. · Journal of Clinical Oncology
Works count: 32
Citation count: 422
H-index: 10
I10-index: 10
Year
Topic
Type